<DOC>
	<DOCNO>NCT02578472</DOCNO>
	<brief_summary>The purpose study evaluate effect JNJ-42847922 , compare zolpidem placebo , drive performance assess mean difference standard deviation lateral position ( SDLP ) force awaken use validated driving simulator test 2 , 4 , 6 8 hour post-evening dose .</brief_summary>
	<brief_title>Pilot Study Evaluate Duration Effects Simulated Car Driving Cognitive Performance After Single Dose JNJ-42847922 , Zolpidem Placebo Healthy Participants</brief_title>
	<detailed_description>This single center , double-blind ( neither Investigator participant know treatment participant receives ) , randomize ( study drug assign chance ) , 3-way cross-over ( medication provide participant different sequence ) , pilot study healthy male female participant . Participants randomly assign 1 6 treatment planning sequence . The study consist 3 part : Screening Phase ( 21 day 1 day prior first dose administration ) , 3-way crossover double-blind , single dose treatment Phase follow-up Phase ( 7 10 day last dose administration ) . The maximum study duration participant exceed 7 week . The double-blind crossover treatment phase consist 3 treatment period separate washout period least 3 day dose . Participants receive either Treatment A ( 2 capsule 20 milligram [ mg ] JNJ-42847922 ) , Treatment B ( 10 mg zolpidem 1 placebo capsule ) Treatment C ( 2 placebo capsule ) treatment period . Driving performance assess primarily mean difference standard deviation lateral position ( SDLP ) road drive test . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Body mass index ( BMI ) ( weight [ kg ] /height^2 [ m^2 ] ) 18 30 kg/m^2 ( inclusive ) Men sexually active woman childbearing potential must agree use condom , men must donate sperm study 3 month receive last dose study drug . In addition , men vasectomy , female partner also use appropriate method birth control least duration A woman childbearing potential must negative serum pregnancy test screen negative urine pregnancy test predose Day 1 period A woman must agree donate egg ( ovum , oocytes ) purpose assist reproduction study least 3 month receive last dose study drug Participant valid driving license 3 year , driven least 5000 kilometer ( km ) past year driving car regularly Women childbearing potential must practice highly effective method birth control consistent local regulation regard use birth control method participant participate clinical study ( , one result less 1 percent per year failure rate use consistently correctly ) Participant clinically significant liver renal insufficiency ; cardiac , vascular , pulmonary , gastrointestinal , endocrine , neurologic ( include cataplexy cognitive impairment ) , hematologic , rheumatologic , psychiatric , metabolic disturbance . A significant primary sleep disorder exclusionary Clinically significant abnormal value hematology , clinical chemistry , urinalysis screening deem appropriate investigator Subject history substance alcohol use disorder accord Diagnostic Statistical Manual Mental Disorders ( 5th edition ) ( DSM5 ) criterion within 6 month screen positive test result ( ) alcohol and/or drug abuse ( opiates [ include methadone ] , cocaine , amphetamine , methamphetamine , cannabinoids , barbiturate , ecstasy benzodiazepine ) screen admission Day 1 study period Current suicidal homicidal ideation/intent/behavior Serology positive hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody ( HCV ) Human immunodeficiency virus ( HIV ) antibody</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Healthy</keyword>
	<keyword>JNJ-42847922</keyword>
	<keyword>zolpidem</keyword>
	<keyword>Placebo</keyword>
</DOC>